Targeting mTOR complex 1 to treat neurological and psychiatric manifestations of tuberous sclerosis complex

Author： Krueger Darcy A   Franz David Neal  

Publisher： Future Medicine

ISSN： 1479-6708

Source： Future Neurology, Vol.6, Iss.2, 2011-03, pp. : 261-271

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Neurobiology of the Tuberous Sclerosis Complex

By  

NeuroMolecular Medicine, Vol. 8, Iss. 4, 2006-12 ,pp. : 531-546

Humana Press, Inc

Access to resources Recommend Favorite

Neuroanatomical Correlates of Memory Deficits in Tuberous Sclerosis Complex

By Ridler K   Suckling J   Higgins NJ   de Vries PJ   Stephenson CME   Bolton PF   Bullmore ET  

Cerebral Cortex, Vol. 17, Iss. 2, 2007-02 ,pp. : 261-271

Oxford University Press

Access to resources Recommend Favorite

TUBEROUS SCLEROSIS COMPLEX: FROM BASIC SCIENCE TO CLINICAL PHENOTYPES

By Fryer A. E.  

Brain, Vol. 127, Iss. 7, 2004-07 ,pp. : 1683-1685

Oxford University Press

Access to resources Recommend Favorite

Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex

By Bolton P.F.  

Brain, Vol. 125, Iss. 6, 2002-06 ,pp. : 1247-1255

Oxford University Press

Access to resources Recommend Favorite

Successful everolimus therapy for SEGA in pediatric patients with tuberous sclerosis complex

By Cappellano A.   Senerchia A.   Adolfo F.   Paiva P.   Pinho R.   Covic A.   Cavalheiro S.   Saba N.  

Child's Nervous System, Vol. 29, Iss. 12, 2013-12 ,pp. : 2301-2305

Springer Publishing Company

Access to resources Recommend Favorite